These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
295 related items for PubMed ID: 10623854
21. CXC chemokine receptor 2 but not C-C chemokine receptor 1 expression is essential for neutrophil recruitment to the cornea in helminth-mediated keratitis (river blindness). Hall LR, Diaconu E, Patel R, Pearlman E. J Immunol; 2001 Mar 15; 166(6):4035-41. PubMed ID: 11238651 [Abstract] [Full Text] [Related]
22. High-mobility group box 1: a novel target for treatment of Pseudomonas aeruginosa keratitis. McClellan S, Jiang X, Barrett R, Hazlett LD. J Immunol; 2015 Feb 15; 194(4):1776-87. PubMed ID: 25589066 [Abstract] [Full Text] [Related]
23. TREM-1 amplifies corneal inflammation after Pseudomonas aeruginosa infection by modulating Toll-like receptor signaling and Th1/Th2-type immune responses. Wu M, Peng A, Sun M, Deng Q, Hazlett LD, Yuan J, Liu X, Gao Q, Feng L, He J, Zhang P, Huang X. Infect Immun; 2011 Jul 15; 79(7):2709-16. PubMed ID: 21555403 [Abstract] [Full Text] [Related]
24. Silencing Toll-like receptor-9 in Pseudomonas aeruginosa keratitis. Huang X, Barrett RP, McClellan SA, Hazlett LD. Invest Ophthalmol Vis Sci; 2005 Nov 15; 46(11):4209-16. PubMed ID: 16249500 [Abstract] [Full Text] [Related]
25. NLRP12 promotes host resistance against Pseudomonas aeruginosa keratitis inflammatory responses through the negative regulation of NF-κB signaling. Deng QC, Deng CT, Li WS, Shu SW, Zhou MR, Kuang WB. Eur Rev Med Pharmacol Sci; 2018 Dec 15; 22(23):8063-8075. PubMed ID: 30556841 [Abstract] [Full Text] [Related]
26. Mammalian target of rapamycin regulates IL-10 and resistance to Pseudomonas aeruginosa corneal infection. Foldenauer ME, McClellan SA, Berger EA, Hazlett LD. J Immunol; 2013 Jun 01; 190(11):5649-58. PubMed ID: 23626014 [Abstract] [Full Text] [Related]
31. Inactivation of the miR-183/96/182 Cluster Decreases the Severity of Pseudomonas aeruginosa-Induced Keratitis. Muraleedharan CK, McClellan SA, Barrett RP, Li C, Montenegro D, Carion T, Berger E, Hazlett LD, Xu S. Invest Ophthalmol Vis Sci; 2016 Apr 01; 57(4):1506-17. PubMed ID: 27035623 [Abstract] [Full Text] [Related]
35. Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection. Hazlett LD, McClellan SA, Barrett RP, Liu J, Zhang Y, Lighvani S. Invest Ophthalmol Vis Sci; 2007 Feb 01; 48(2):797-807. PubMed ID: 17251480 [Abstract] [Full Text] [Related]
37. B7/CD28 costimulation is critical in susceptibility to Pseudomonas aeruginosa corneal infection: a comparative study using monoclonal antibody blockade and CD28-deficient mice. Hazlett LD, McClellan S, Barrett R, Rudner X. J Immunol; 2001 Jan 15; 166(2):1292-9. PubMed ID: 11145712 [Abstract] [Full Text] [Related]
38. Galectin-1-mediated suppression of Pseudomonas aeruginosa-induced corneal immunopathology. Suryawanshi A, Cao Z, Thitiprasert T, Zaidi TS, Panjwani N. J Immunol; 2013 Jun 15; 190(12):6397-409. PubMed ID: 23686486 [Abstract] [Full Text] [Related]
39. TREM-2 promotes host resistance against Pseudomonas aeruginosa infection by suppressing corneal inflammation via a PI3K/Akt signaling pathway. Sun M, Zhu M, Chen K, Nie X, Deng Q, Hazlett LD, Wu Y, Li M, Wu M, Huang X. Invest Ophthalmol Vis Sci; 2013 May 17; 54(5):3451-62. PubMed ID: 23611998 [Abstract] [Full Text] [Related]
40. Role of innate and adaptive immunity in the pathogenesis of keratitis. Hazlett LD. Ocul Immunol Inflamm; 2005 May 17; 13(2-3):133-8. PubMed ID: 16019672 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]